Notice Number: NOT-NS-17-034
Key Dates
Release Date: June 12, 2017
PAR-16-155
Issued by
National Institute of Neurological Disorders and Stroke (NINDS)
Purpose
The purpose of this Notice is to inform interested applicants that the expiration date for the Funding Opportunity Announcement (FOA) PAR-16-155 "NeuroNEXT Clinical Trials (U01)" will be extended by one receipt cycle. An additional non-AIDS application due date of December 6, 2017 has been added for this FOA. This FOA expires on December 7, 2017.
The Key Dates table is updated accordingly:
Part 1. Overview Information
Key Dates
Application Due Date(s) |
August 2, 2016; December 6, 2016; April 4, 2017; August 3, 2017; December 6, 2017, by 5:00 PM local time of applicant organization. All types of non-AIDS applications allowed for this funding opportunity announcement are due on these dates. Applicants are encouraged to apply early to allow adequate time to make any corrections to errors found in the application during the submission process by the due date. |
Scientific Merit Review |
October, 2016; February, 2017; June, 2017; October, 2017; February 2018 |
Advisory Council Review |
January, 2017; May 2017; October, 2017; January, 2018; May 2018 |
Earliest Start Date(s) |
March, 2017; July, 2017; December, 2017; May, 2018; September 2018 |
Expiration Date |
December 7, 2017 |
All other aspects of this FOA remain the same.
Inquiries
Please direct all inquiries to:
Codrin Lungu, MD
National Institute of Neurological Disorders and Stroke (NINDS)
Telephone: 301-496-9135
Email: [email protected]
and Human Services (HHS)
